Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases

American Journal of Cardiology

Volumn 88, Issue 2, 2001, Pages 173-175

  Kalela, Anne ^a   Laaksonen, Reijo ^b,c   Lehtimäki, Terho ^b   Koivu, Tommi A ^a   Höyhtyä, Matti ^d   Janatuinen, Tuula ^e   Pöllänen, Perttu ^b   Vesalainen, Risto ^e   Saikku, Pekka ^f   Knuuti, Juhani ^e   Nikkari, Seppo T ^a,e  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Diabor Oy   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTERY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME BLOOD LEVEL; ENZYME RELEASE; GENDER; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTICHOLESTEREMIC AGENTS; DOUBLE-BLIND METHOD; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, GENETIC; PRAVASTATIN;

EID: 0035879774     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01616-2     Document Type: Article

References (16)

1. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)
2. The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression
3. Mechanisms modifying atherosclerotic disease - From lipids to vascular biology
4. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions
5. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits
6. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
7. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages
8. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
9. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis
10. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization
11. Effect of statins on C-reactive protein in patients with coronary artery disease
12. Statins and C-reactive protein
13. Inhibition of proinflammatory cytokine production by pravastatin
14. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
15. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
16. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers